2.36

4.07% -0.10

After Hours: 2.36

Connect Biopharma Holdings Ltd (CNTB)

Overview News Price History Option Chain Discussions Forecast

Connect Biopharma Holdings Ltd stock is traded at $2.36, with a volume of 365.29K. It is down -4.07% in the last 24 hours and up +8.76% over the past month. Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Previous Close:

$2.46

Open:

$2.45

24h Volume:

365.29K

Relative Volume:

1.09

Market Cap:

$148.59M

Revenue:

$233.00K

Net Income/Loss:

$-64.61M

P/E Ratio:

-2.0458

EPS:

-1.1536

Net Cash Flow:

$-58.32M

1W Performance:

-0.84%

1M Performance:

+8.76%

6M Performance:

+4.42%

1Y Performance:

+101.83%

1-Day Range:

$2.30

$2.46

1-Week Range:

$2.30

$2.51

52-Week Range:

$1.0502

$3.82

Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile

Name

Connect Biopharma Holdings Ltd

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

858-727-1040

Address

3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

CNTB's Discussions on Twitter

Compare CNTB vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNTB Connect Biopharma Holdings Ltd	2.36	149.85M	233.00K	-64.61M	-58.32M	-1.1536
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-01-25	Initiated	Lake Street	Buy
Oct-31-25	Initiated	BTIG Research	Buy
Jun-12-25	Initiated	H.C. Wainwright	Buy
Mar-04-24	Initiated	H.C. Wainwright	Buy
Apr-13-21	Initiated	Jefferies	Buy
Apr-13-21	Initiated	Piper Sandler	Overweight
Apr-13-21	Initiated	SVB Leerink	Outperform

View All

Connect Biopharma Holdings Ltd Stock (CNTB) Latest News

Jul 01, 2026

Form 4 Connect Biopharma Holdings Ltd For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

Connect Biopharma (CNTB) director granted 3,738 fully vested shares as fees - Stock Titan

Jul 01, 2026

Connect Biopharma (NASDAQ: CNTB) director receives 6,718-share award as 2026 board compensation - Stock Titan

Jul 01, 2026

Jun 30, 2026

CCORF Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $6 - Moomoo

Jun 30, 2026

Jun 29, 2026

Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 26, 2026

Piper Sandler initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com Canada

Jun 26, 2026

Piper Sandler initiates Connect Biopharma stock with overweight rating - Investing.com

Jun 26, 2026